>>> US Research Calls

Research Calls

  • Upgrades:
    • Blackbaud (BLKB) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $84
    • CEMEX S.A. (CX) upgraded to Buy from Neutral at Goldman; tgt raised to $9
    • Cerevel Therapeutics (CERE) upgraded to Overweight from Equal Weight at Wells Fargo; tgt $30
    • Design Therapeutics (DSGN) upgraded to Neutral from Sell at Goldman; tgt $6
    • Deutsche Bank (DB) upgraded to Buy from Neutral at Citigroup
    • Ionis Pharma (IONS) upgraded to Neutral from Sell at Citigroup; tgt raised to $36
    • Neurocrine Biosciences (NBIX) upgraded to Buy from Neutral at Guggenheim; tgt $145
    • Procore Technologies (PCOR) upgraded to Buy from Neutral at Goldman; tgt raised to $75
    • Qorvo (QRVO) upgraded to Buy from Hold at Summit Insights
    • Verisk Analytics (VRSK) upgraded to Buy from Underperform at BofA Securities; tgt raised to $243
    • Weave Communications (WEAV) upgraded to Outperform from Mkt Perform at Raymond James; tgt $6
    • Wix.com (WIX) upgraded to Outperform from Mkt Perform at Raymond James; tgt $96
  • Downgrades:
    • Builders FirstSource (BLDR) downgraded to Neutral from Outperform at Robert W. Baird; tgt $96
    • DHT (DHT) downgraded to Hold from Buy at Jefferies; tgt lowered to $10
    • Fulcrum Therapeutics (FULC) downgraded to Neutral from Buy at Goldman; tgt lowered to $3
    • Incyte (INCY) downgraded to Neutral from Buy at BofA Securities; tgt $84
    • QuinStreet (QNST) downgraded to Hold from Buy at Craig Hallum
    • Revolve Group (RVLV) downgraded to Mkt Perform from Outperform at Raymond James
    • Spirit Aerosystems (SPR) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $28
    • TriplePoint Venture Growth (TPVG) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $10
    • Upwork (UPWK) downgraded to Neutral from Buy at BofA Securities; tgt $9
    • Wingstop (WING) downgraded to Neutral from Buy at Citigroup; tgt raised to $224
  • Others:
    • HomeTrust Bank (HTBI) assumed with an Overweight at Piper Sandler; tgt $25
    • Vertex Pharma (VRTX) assumed with an Overweight at Piper Sandler; tgt $385
    • ZoomInfo (ZI) initiated with a Buy at DA Davidson; tgt $30